Myocardial Mass Determination by FFRct and Absolute Coronary Blood Flow
MyoMass
1 other identifier
observational
60
1 country
1
Brief Summary
The background for performing the present study is to compare the mass calculations by CT scanning and by invasive absolute blood flow measurements and thereby corroborating both methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2017
CompletedFirst Posted
Study publicly available on registry
January 9, 2018
CompletedStudy Start
First participant enrolled
February 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedJuly 24, 2019
February 1, 2018
10 months
December 28, 2017
July 23, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Comparison of Mass and flow
To compare relative myocardial mass distribution (i.e. mass of the respective territories of LAD, LCX and RCA) by CT scanning to normalized hyperemic blood flow in the three major myocardial territories as assessed by absolute flow measurements and FFR in patients with an indication for multivessel FFR measurement.
3 months
Comparison of Mass and flow in the LAD
To compare relative myocardial mass belonging to a proximal or a mid segment of one of the major coronary arteries measured by CT scanning to invasive absolute flow and FFR measurement in that particular proximal or mid coronary artery in patients undergoing single or multivessel PCI.
3 months
Interventions
Absolute maximum flow will be measured, using the RayFlow® multifunctional monorail infusion catheter. (This measurement takes a few minutes per artery, does not require any additional drug, but only 50-100 ml of saline per artery, and is not associated with any additional risk for the patient compared to the regular invasive procedure.
Eligibility Criteria
Sixty patients will be included who are scheduled 1. Either for multivessel FFR/PCI fulfilling the following criteria and not meeting any of the exclusion criteria (prospective group) 2. Or patients in whom both coronary CT scanning and invasive exams have been performed already for clinical reasons and of whom "complete data" are available already (retrospective group)
You may qualify if:
- Presence of multivessel coronary disease with an indication for multivessel FFR and/or PCI or patients with single vessel disease scheduled for FFR/PCI of that single coronary artery
- Availability of a coronary CT scan performed prior to the scheduled invasive investigation. The time difference between the CT scan and the invasive exam should be less than 3 months.
- Focal lesions only
- Normal left ventricular function
- Age \< 75 years
- Note: previous uncomplicated PCI in any of the coronary arteries is permitted
You may not qualify if:
- Inability to give informed consent
- Diffuse coronary disease
- Tortuous or calcified arteries interfering with reliable invasive FFR assessment
- Previous myocardial infarction or ejection fraction less than 60% by echocardiography or ventriculography or less than 50% by nuclear methods
- Atrial fibrillation interfering with high quality coronary CT scanning
- Contra-indications for CT scanning
- Left main stenosis
- Age \> 75 years
- Pregnancy or desired pregnancy in the future
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catharina Hospital
Eindhoven, North Brabant, 5623EJ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nico HJ Pijls, MD, PhD
Catharina Ziekenhuis Eindhoven
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. PHD
Study Record Dates
First Submitted
December 28, 2017
First Posted
January 9, 2018
Study Start
February 1, 2018
Primary Completion
December 1, 2018
Study Completion
March 1, 2019
Last Updated
July 24, 2019
Record last verified: 2018-02